- TypeConference
- Location Online Event
- Date 05-05-2023 - 06-05-2023
Research/Science
Medical/Healthcare/Hospital
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
. Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
. Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
. Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
. Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
Virtual: https://go.evvnt.com/1502935-3?pid=6581
Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don C. Yoo, MD